Skip to main content

Table 6 The mean lifetime attributed cancer mortality risks due to whole lung low dose radiotherapy (with a prescribed dose equal to 1 Gy) in 3D-CRT AP–PA technique for adult male and female patients at different ages

From: Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia

  Age at exposure time (years)
20 30 40 50 60 70 80
Male
Stomach 0.122 0.093 0.087 0.075 0.064 0.046 0.023
Liver 0.131 0.091 0.091 0.080 0.068 0.046 0.023
Lung 1.767 1.819 1.252 1.217 1.088 0.831 0.491
Other 0.281 0.197 0.185 0.162 0.122 0.076 0.036
All solids 2.301 1.633 1.615 1.534 1.342 0.998 0.573
Female
Stomach 0.168 0.122 0.116 0.110 0.093 0.075 0.046
Liver 0.068 0.051 0.046 0.046 0.040 0.029 0.017
Lung 3.569 2.492 2.480 2.387 2.141 1.638 0.948
Breast 1.232 0.744 0.427 0.232 0.110 0.061 0.024
Other 0.309 0.216 0.204 0.181 0.145 0.099 0.050
All solids 5.209 3.597 3.334 3.041 2.594 1.942 1.114
  1. Risk values are presented as incidence probability per 100 individuals